Weixing Du

机构：Hubei University of Medicine

发表论文 44 篇 · 总被引 1994 次 · h-index 12

代表论文

• Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City, China (2020 · Frontiers in Cellular and Infection Microbiology · 被引 34)
• Ubiquitination of SARS-CoV-2 ORF7a Prevents Cell Death Induced by Recruiting BclXL To Activate ER Stress (2022 · Microbiology Spectrum · 被引 27)
• Molecular characterization of SARS-CoV-2 nucleocapsid protein (2024 · Frontiers in Cellular and Infection Microbiology · 被引 21)
• Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide (2024 · Journal of Virology · 被引 18)
• Comparison of Clinical Features and Outcomes of Medically Attended COVID-19 and Influenza Patients in a Defined Population in the 2020 Respiratory Virus Season (2021 · Frontiers in Public Health · 被引 16)
• Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response (2022 · Infectious Agents and Cancer · 被引 12)